CA1230161A - Dna sequencing - Google Patents

Dna sequencing

Info

Publication number
CA1230161A
CA1230161A CA000477173A CA477173A CA1230161A CA 1230161 A CA1230161 A CA 1230161A CA 000477173 A CA000477173 A CA 000477173A CA 477173 A CA477173 A CA 477173A CA 1230161 A CA1230161 A CA 1230161A
Authority
CA
Canada
Prior art keywords
dna
bands
strands
dna fragments
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000477173A
Other languages
French (fr)
Inventor
Lyle R. Middendorf
John A. Brumbaugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska
Original Assignee
University of Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska filed Critical University of Nebraska
Application granted granted Critical
Publication of CA1230161A publication Critical patent/CA1230161A/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44704Details; Accessories
    • G01N27/44717Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/44721Arrangements for investigating the separated zones, e.g. localising zones by optical means
    • G01N27/44726Arrangements for investigating the separated zones, e.g. localising zones by optical means using specific dyes, markers or binding molecules
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44704Details; Accessories
    • G01N27/44717Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/44721Arrangements for investigating the separated zones, e.g. localising zones by optical means
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/803Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Electrochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

DNA SEQUENCING

ABSTRACT OF THE DISCLOSURE
To sequence long strands of DNA, cloned strands having lengths longer than 100 bases are, in one embodi-ment, marked on one end with biotin. These strands are divided into 4 aliquots and each aliquot: (1) is uniquely chemically treated to randomly terminate the strands at the non-biotinylated end at a selected type of base; and (2) is moved continuously by electrophoresis through a different one of four identical channels. In the one embodiment, the strands are randomly terminated at a selected base type and they are moved into avidin, which due to high affinity, combines with the biotin marked ends of shorter strands before the longer strands are fully resolved in the gel.
The avidin is marked with fluorescein, the strands are scanned and the signals are decoded. In another embodiment, the strands are synthesized, with termina-tion at a selected base type and marked either by the above method or by ethidium bromide.

Description

~23~ 6~ ^

DNA SEQUENCING
This invention relates to the sequencing of DNA
strands.
- In one class of techniques for sequencing DNA, identical cloned strands of DNA are marked. The strands are separated into four batches and either individually cleaved at or synthesized to one of the four base types, which are adenine, guanine, cytosine and thymine (hereinafter A, G, C and ~).
The adenine-, guanine-, cytosine- and thymine-cleaved batches are then electrophoresed for separation. ~he rate of electrophoresis indicates the DNA sequence.
In a prior art sequencing technique of this class, the DNA strands are marked with a rad;oactive marker, cleaved at a different base type in each aliquot, and after being separated by electrophoresis, fi]m is exposed to the gel and developed to indicate the sequence of the bands.
The range of lengths and resolution of th;s type of static detection is limited by the size of the apparatus.
In another prior art sequencing technique of this class, single strands are synthesized to a different base type in each aliquot, and the ~3~

strands are marked radioactively for later detection.
It is also known in the prior art to use fluorescent markers for marking proteins and to pulse the fluorescent markers with light to receive an indication of the presence of a particular protein from the fluorescence.
The above prior art techniques for DNA
sequencing have several disadvantages such as: tl) they are relatively slow; ~2) they are at least partly manual; and (3~ they are limited to relatively short stranas of DNA. -In accordance with the invention, a method for sequencing DNA comprises the steps of preparing cloned DNA strands; preparing from the c].oned DNA
strands fragmented DNA strands with random lengths terminating at different ones of the adenine base, guanine base, cytosine base and thymine base and marking the pieces; applying samples of the fragmented DNA strands after terminating at their respective bases to at least one channel of separating apparatus; separating the strands within at least one channel so that the first bands to be moved completely through the channels are fully resolved while the last bands are unresolved in a ~;~3~

continuous process such that at ]east ten percent of the bands are resolved and moved through the channels while the least mobile bands are yet unresolved near the entrance end of the channel; and identifying and recording the time sequence of the bands in the channel and whether the termlntaion is at an adenine base, guanine base, thymine base or cytosine base in the bandO
Advantageously, the step of separating includes the step of separating the strands by gel electrophoresis and more specifically, the step of separating includes the s~ep ~of separating the strands by ~PLC. Further, the step of preparing a first batch may include the step of cleaving the strands at an adenine on pieces ~ith random ]engths.
In one embodiment, four batches of fragments are prepared each batch being terminated at a different one of A, G, C and T bases and the step of separating includes the step of separating each batch in a corresponding channel. ~here is some advantage in including the steps of applying at least one calibration time base source of DNA to at least one channe] interlaced among the four channels. Preferably, the strands terminating at different bases are identified.

~23U~

Advantageously, the step of identifying includes the steps of marking the DNA strands on one end with biotin before separating; attachlng fluorescent markers to the avidin; and moving said bands sequentially from the gel while maintaining each fragment in each channel separate into a means for marking with fluorescent-marked aviden by combining the fluorescent avidin with the biotin end markers.
Moreover, the step of identifying may further include the steps of: moving the bands in sequence through a medium; scanning said bands with laser light having a narrow band wi~th substantially conforming to the optimum adsorption spectrum of the fluorescent markers; pulsing the laser light with pulses of shorter duration than three nanoseconds;
detecting the fluorscent emission from ~he marker across a narrow selective ban2 width conforming substantially to the optimum emission spectrum of the markers through a second period of time; said second period of time beginning at least fifty nanoseconds from the start of its corresponding pulse of laser light and terminati.ng at a time no greater than one hundred fifty nanosecon~s from the start of the pulse of the laser light; and identifying and recording the time sequence of each of the channels so as to indicate the seauence of DNA fragments~
Apparatus for performing the DNA sequencing comprises separating apparatus; said separating apparatus having at least one channel and at least one channel-introducing section adapted to receive DNA fragments terminated at different ones of the four nucleic acid molecules, A, G, C and ~; means for removlng separated bands of the DNA fragments from the end of said separating apparatus prior to the resolution of the last to be r~eso]ved bands; and means for sensing four separate groups of DNA
fragments in accordance with the terminating base.
Advantageously, the separating apparatus is a gel electrophoresis apparatus or capillary chromatographic equipment. The apparatus may include means for marking said DNA fragments prior to their entrance into the electrophoresis gel with biotin; means for attaching a fluorescent marker to avidin; means for marking said DNA fragments af~er they have been electrophoresed through said electrophoresis apparatus with fluorescenated 20 avidin; means for selectively pulsing said markers with light; means for detecting the fluorescence of ~23~

said marker across a time period in which background fluorsecence is reduced; and sai~ means for detecting including means for con~ertlng said fluorescence into electrical signals indicating the time sequence of bands of DNA marked with fluorescence corresponding to each of the DNA
fragments cleaved at different ones of the nucleic acid groups.

One embodiment of apparatus for performing DNA
sequencing comprises: first gel electrophoresis apparatus; said first gel electrophoresis apparatus having at least four separate channel-lntroducing sections each adapted to receive DNA fragments cleaved at different ones of the four nucleic acid molecules, A, G, C and T; and means for electrophoresing separated bands of the DNA
fragments from the end of said electrophoresis apparatus prior to the resolution of the last to be resolved bands.
Advantageously, the apparatus also includes:
means for marking said DNA fragments prior to their entrance into the electrophoresis gel with biotin;

said means for electrophoresing said bands from said gel including means for maintaining four separate groups of DN~ fragments in accordance with the 3L23~

nucleic acid molecu~e at which they were cleaved;
means for marking said DN~ fragments after they have been electroprhoresed through said electrophoresis apparatus with avidin; and means for attaching a flourescent marker to said avidin. There may be included in this embodiment means for selectively pulsing said markers with light, means for detecting the flo~rescence of said marker across a time period in which backgroung flo~rescence is reaucea; and said means for detecting including means for converting said flourescence into electrical signals indicating the time sequence of bands of DNA marked with flourescence corresponding to each of the DNA
fragments cleaved at different ones o~ the nucleic acid groups.
In another embodiment, apparatus for performing DNA sequencing comprises: first gel electrophoresis apparatus; said first gel electrophoresis apparatus inc]uding at least four separate tubes each adapted to receive DNA fragments terminated at differnet ones of the four bases, A, G, C and T; and means for electrophoresing separated bands of the DNA fraqments from the end of said elec~rophoresis apparatus prior to the resolution of the last to be resolYed bands. There may be ~2;~

included in this embodiment means for marking said DNA fragments prior to their entrance into the electrophoresis gel with biotin; said means for electrophoresing said bands from said gel inc]uding means for maintaining four separate groups of DNA
fragments in accordance with the nucleic acid molecule at which they were cleaved; means for marking said DNA fragments after they have been electrophoresed through said electrophoresis apparatus with avidin; and means for attaching a flourescnet marker to said avidin.
The above noted and other features of ~he invention will be better understood from the following detailed description when considered with reference to the accompaning drawings in which:
FIG. 1 is a block diaqram of an embodiment of the invention;
FIG. 2 is a block diagram of another embodiment of the invention;
FIG. 3 is a simplified schematic of a portion of the embodiment of FIGS. 1 and 2;
FIG. 4 is an alternative embodiment of the portion of FIG. 3;

FIG. 5 is another alternative embodiment of the portion of FIG. 3;

~:~3~

FIG. 5 is a block diagram of a portion of the embodiments of FIGS. l and 2;
FIG. 7 is a logical circuit diagram of a portion of the block diagram of FIG. 3; and FIG. 8 is a schematic circuit diagram of a portion of the embodiments of FIGS. l and 2.
In FIG. l, there is shown a block diagram of a DNA sequencing system lO having a biotin labe].ing system ll, a DN~ cleavage system ]2, a separating system 14, a detection and processing sys~em 16 and a source of standard length DMA 18. Biotin labeling takes place before dividing the DNA cl.oned strands into 4 aliquots.
The biotin from any suitable commercia]. source is added to the cloned strands of more than lO0 bases in a container as indicated at 31~ The biotin preparation must be sufficient to mark at least one end of a substantia]. proportion of the DMA fragments with the biotln in a manner known in the art.
Biotin is selected be~ause of its affinity to avidin and because it is not a large molecule, which in the latter case when added to the DNA fragments might substantially dominate the mobility cf the DN~ fragments during electrophoresisO Being a small.
molecul.e, it does not prevent the discrimination ~23~16~

betweer. different DNA fragments within the separating system 14.
Although biotin has been selected as a marker which may be combined later with a larger molecule sush as avidin, other markers may be used. They must have characteristics which enable them to be attached to a DNA fragment and to have a strong affinity to a larger molecule which may be marked with a fluorescein or other suitably detectable material. ~hey must also be of such a size and have such chemical character;stics to not obscure the normal differences in the mobilities between the different fragments due to cleavages at different ones of the adenine, guanine, cytosine ana thymine bases.
In addition, a radioactive marker such as radioactive phosphorus or radioactive sulfur~ radio-active carbon or tritium may be incorporated into the DMA molecules such that after separationr strands are combined with scintillation liquid.
~he DNA cleavage system 12 communicates in four paths and the source of standard length DNA 18 communi-cates in one path within the separating system 14 to permit passage of DNA fragments and standard fragments thereto in separate paths. ~he separating system 14, which sequences strands by separation, communicates with 123~

the detection and processing system 15 which analyzes the fragments by comparison with each other and the standard from the source of standard length DNA 18 to derive information about the DNA sequence of the original fragments.
The DNA c]eavage system 12 incl~des four sources 20A, 20G, 20C, 20T of fragments of the same cloned DNA
strand. This DNA strand is normally greater ~han lO0 bases ln lenqth and is then further cleaved by chemical treatment to provide different lengths of fragments in each of four containers 20A, 20G,-20C and 20T.
In one embodiment, the container 20A contains fragments of DNA strands randomly cleaved by a chemical treatment for A; the container 20G contains fragments of DNA strands randomly cleaved by a chemical treatment for G; container 20C contains fragments of DNA strands randomly cleaved by a chemical treatment for C and container 20T contains fragments of 3NA strands randomly cleaved by a chemical treatment for T. Thus, ldentica~
fragments in each container have been cleaved at different bases of a given base type by the appropriate chem~cal treatment.
The fragments in the containers are respective]y referred to as A-DNA fragments, G-DNA fragments, C-DN~
fragments and T-DNA frag~ents from the containers 20A, S 23~6~

20G, 20C and 20T respectively. These fragments are flowed from the containers 20~/ 20G, 20C and ~OT through corresponding ones of the conduits 22A, 22G, 22C and 22T
into contact with the separating system 14.
The source of standard length DNA 18 includes a source of reference DNA fragments of known but different lengths which are flowed ~hrough a conduit 22S to the separating system 14. These reference fragments have known lengths and therefore their time of movement through the separating system 14 forms a clock source or timing source as explained hereinafter. While in the preferred embodiment the cloned strands of 100 bases are marked with biotin before being divided into four batches, they may be marked instead after dividing into four batches but before the selected chemical treatment.
The separating system 14 includes five electropho-resis channels 26S, 26A~ 26G, 26C and 26T. The electro-phoresis channels 26S, 26A, 26G, 26C and 26~ include in the preferred embodiment, gel electrophoresis apparatus with each path length of gel being identical and having the same field applied across it to move samples continuously through five channels. The ge]s and fields are selected ~o provide a mobility to DNA strands that does not differ from channel to channel by more than 5 in velocity. In addition, the field may be varied over ~z~

time to enhance the speed of larger molecules after smaller molecules have been detected, as well as to adjust the velocities in each channel based on feedback from the clock channel to compensate for differences in each channel such that the mobilities in each channe]
are within the accuracy required to maintain synchronism among the channels.
Preferably the gels are of the same materials~
chemical derivatives and lengths and the electric fields are within 5~ of the intermediates of each other in each channel. ~owever, more than one reference channel can be used such that a reference channel is adjacent to a sample channel in order to minimize the requirements for uniformity of DNA movement in the gel for all channels.
The electrophoresis channel 26S receives fragments of known length DNA marked with biotin and moves them through the gel. Similarly, each of the electrophoresis channels 26A, 26G, 26C and 26T receives biotin-labeled fragments from the cleavage system 20A, 20G, 20C and 20T
and moves them in sequence through the sample elec-trophoresis channels, with each being moved in accor-dance with its mobility under a field ident;cal to that of the reference electrophoresis channel 26S.
To provide information concerning the DNA sequence, the detection and processing system 16 includes flve ~23~16~

avidin sources 30S, 30A, 30G, 30C and 30T; five detection systems 32S, 32A, 32C-, 32C and 32T and a correlation system 34. Each of the avidin sources 30S, 30A, 30G, 30C and 30T is connected to the detectinq systems 32S, 32A, 32G, 32C and 32T. Each of the outputs from corresponding ones of the electrophoresis channels 26S, 25A, 26G, 26C and 26T within the separating system 14 is connected to a corresponding one of the detection systems 32S, 32A, 32G, 32C and 32T. In the detection system, avidin with ~luorescent markers attached and DNA fragments are combined to provide avidin marked DNA
fragments with fluorescent markers attached to the avidin to a sample volume within the detection system for the detection of bands indicating the presence or absence of the fragments, which over time relates to their length.
The output from each of the detection systems 32S, 32A, 32G, 32C and 32T are el.ectrically ~onnected through conductors to the correlation system 34 which may be a microprocessor system for correlating the ;nformation from each of the detection systems to pro-v1de information concerning the DNA sequence.
The avidin sources 30S, 30A, 30G, 30C and 30T each contain avidin purchased from kno~n suppliers, with each avidin molecule in the pre~erred embodiment combine~

~3V~.61 with three fluorescein moleules. The avidin ~ources are arranged to contact the ~NA fragments and may be in a section of gel placed adjacent to the electrophoresis channel. In this use, this section of the gel should have a p~I of approximately 8 to avoid movement of the three fluorescein-marked avidin by electrophoresis. when the biotinylated DN~ strands reach the section of gel that has a p~ of 8, they will pick up the fluoresceinated avidin which moves very slowly or is stationa~y in this section of the ge].
To prepare the second section of gel with fluoresceinated avidin, the fluoresceinated avidin may be electrophoresed from the exit end of the channel inwardly. In this embQdiment, it moves in this direction slowly because its pI is slightly higher than the p~ of the second section of gel. Alternatively, it may be mixed in gel.
Because the fluorescein-avidin-biotin-DNA complex molecule is acidic in the pn 8 gel, it will continue to move out of this section of the gel where it is then passed to a sample volume within the detection system by an eluant. The sequences of separation determine~
before the attachment of avidin are maintained and not substantially altered. In the alternative, the bands of DNA fragments may be e]ectrophoresed ;nto a more mobile ~L~3(~

liquid containing fluorescein marked avidin for combina-tion with the avidin. The avi.din binds se1.ectively to the biotin attached to the ends of the DNA fragments and unreacted fluoresceinated avidin is separated from the fluorescein-avidin-biotin-DNA complex by standard techniques such as chromatography.
The detection systems each include an optical system for detecting the presence or absence of bands and converting the detection of them to electrical sig~
nals which are applied electrically to the correlation system 34 indicat;nq the sequence of the fragments with respect to both the standard fragments from the source o standard length DNA 18 and the A, G, C and T frag-ments from the containers 20A, 20G, 20C and 20 respectively.
In FIG. 2, there is shown a simplified block diagram of another embodiment of chromatographic appara-tus A10. This apparatus is similar to the chromatographic apparatus 10 of FIG. 1 and the compo-nents are identified in a similar manner with the reference numbers being prefixed by the letter A.
In this embodiment, insteafl of the containers for DNA and chemical treatment for A, G, C and T of the embodiment of DNA sequencing system 10 shown at 20A, 20G, 2QC and 20~ in ~IG. 1, the chromatographic ~23~3~6~

apparatus 10 includes containers for treatment of the DNA in accordance with the method of Sanger described by F. Sanger, S. Nicklen and ~.R. Coulson, ~DNA Sequencing with Chain-Terminating Inhibiters," Proceedings of the National Academy of Science, USA, Vol. 74, No. 12, 5463-5467~ 1977, indicated in the embodiment AlO of FIG. 2 at A20A, A20G, A20C and ~20T shown as a group generally at A12.
In this method, the strands are separated and used as ~emplates to synthesize DNA wi~h synthesis terminating at given base types A, G, C or T in a r~ndom manner so as to obtain a plurality of different molecular weight strands. The limited synthesis is obtained by uslng nucleotides which will terminate synthesis and is performed in separate containers, one of which has the special A nucleotide, another the special G nucleotide, another the special C nucleotide and another the special ~ nucleotide. These special nucleotides may be dideoxy nucleotides or marked nucleo~ides, both o which would terminate synthesis.
So, each or the four batches will be ~erminated at a different one of the types of bases A, G, C and T
randomly.
In this embodiment, the fragments may be marked by biotin at one end in the manner shown in FIG. 1.

~8 lg ~owever, in the preferred embodiment of FIG. 2, lnstead of labeling with biotin, thle fragments are labeled by an inverted complementary repeat of DNA as shown at A]l before bein~ applied to the channels ;ndicated at A12 in FIG. 2. The desi~n of in~erted complementary repea~
takes advantage of the pro~ess of designlnq small DNA
frasments known as oligonucleotides. This process is widely described in the literature as we~l as such patents as Phosphoramidite Components and Processes (U.S~ pa~ent 4,415~732), After the electrophoresis, the inverted complemen-tary repeat forms a hairpin from a pa]indrome of duplex DNA, which is then combined w;th ethidium bromide and detected by the detection system using a wavelength of 7ight appropriate to the intercalated ethidium bromide rather than wavelengths of ~ight appropriate to the fluorescein marking. If one uses highly æen itive detection techniques, the inverted repeat would not be used and detection would be accompllshed either by 1 20 sensing ethidium bromide that intercalated between por-¦ tions of the unknown DNA that happened to form duplex DNA, or by ethidium bromide that a~tached to single stranded DNA~ or by the inherent fluorescence of the DNA
itself. If one used radioactive markers, detectlon ~23V~

would be accomplished by sensing light given off.by the combination of the radioactive marker and scintillation fluid.
In FIG. 3, there is shown a separating system 26A
which includes a slab of gel 27 as known in the art with five sa~ple dispensing tubes in~ioated generally at 29A terminating in alignea slots 51 in the gel. 27 on one end, with such slots in contact with a negative potential buffer well. 29 having a negative electrode 47A, and flve exit tubes at the other end located at 31A terminating in apert~lres in the gel 27, as well as a positive potential buffer well 31 having a positive electrode A53. The material to be electrophoresed is inserted into slots 29A and due to the field across the gel 27 ~oves from top to bottom in the gel and into the appropriate corresponding exit tubes of the group 31A.
The gel slab 27 has glass plates 27A and 27~ on either side to confine the sample and gel. Buffer fluid from the buffer well 31 is pumped at right angles to the gel 27 from a source at A57 by pumps connected to tubes 31~
to pull fluid therethrough. The buffer fluid p;cks up any DNA that is electrophoresed into the exit holes 3~A
and makes its way to sensing equipment ~o be described hereinafter or to provide communication with other gel
2~
3(3~

slabs for further electrophores;s of the DNA strands being electrophoresed from the slab 27.-In FIG. 4, there is shown another embodiment B26Aof gel electrophoresis having a negative-potential buffer for the A channel indicated genera]ly at B29A, a gel electrophoresis channel for ~ terminated DNA
indicated at B27A and a positive potential buffer for the channel îndicated at B31A. This embodiment is intended to provide a thin cylindrical gel for each channel so as to permit easier temperature control and thus alleviate changes in migration rates by different temperatures such as may occur across the slab 27 (FIG~
3~. In addition, the field could be adjusted independently for each channel to maintain proper synchronization.
For this purpose, the channel B27A includes a 0.5 to a 1 millimeter inner diameter pyrex column such as a chromatographic column indicated at 33 with a gel inside of it. The gel is prepared by inserting it in the column while warm and permitting it to harden. The column 33 is of sufficient length to separate the DNA.
Fluoresceinated avidin may be initially e~ectrophsresed upward ~rom its exit end shown at 35 to meet with DNA
entering from its entrance end shown at 37 in the embodiment wh-ch uses biotin-avidin-fluorescein as a ~23~

marker. mhe column may be temperature controlled by a conventional chromatographlc temperature controlling apparatus 39 which is a glass casing about the column which receives a liquid at one end such as at 41 and removes it at 43.
At one end of the channel s27A is the buffer B29A
adapted to provide a buffer solution in a p~exiglas surrounding cup shaped container 45, which buffer ex-tends over the entering end 37 and contains within it a negative voltage electrode 47.

At the exit end, there is similar].y mounted a buffer compartment 51 containing buffer which is grounded by an electrode 53 and emerses in buffer the exit end 35 of the gel column B27A. It may be made of plexiglass and may be shaped with a reducing oriface ending in a micro-orifare 55 at its lower end to permit the flow of buffer therethrough containing DNA which emerged from exit end 35 for detecting with a chopped light source as described above. To supply new buffer, a buffer reservoir 57 is connected through a pump 59 to the top of the buffer 51, with the fl.ow rAtes being designed to prevent a vortex near the exit end 35 and to permit a flow rate sufficient for optimum signal-to-~oise ratio of buffer~ Another embodiment would ~Z3~

transfer the flowing buffer-DNA solution to a f]ow-through cell for detection in a spectrofluorometer or specifically designed HPLC fluorescence detection.
In one embodiment, the buffer may include the ethidium bromide for exciting 300 or 390 nanometers and detecting at 590 nanometers.
In FIG. 5, there is shown still another embodiment C26A which may be substituted for the column 33 and gel and includes capillary columns 61, 63 and 65 as commonly used in capillary electrophoresis. These columns may be filled with buffer solution rather than a gel and be used for electrophoresis. In such a case, several capil]aries may be used as a substitute for one column of the embodiment of FIG. 4. Thus, the same band of A, G, C or T type bases might flow through several parallel bundles of capillaries, or they might flow through on]y one capillary per type of base.
The separation path such as gel channels or capillary ~ube length should be no tonger than two meters for a range of lengths of DNA from 50 to 10,000 or more bases. However, as the range of DNA ]engths increase, the time required increases. Also, the time required for each separation is in the range of from 1/2 second to 5 minutes for each added base of length separation.

~23~
2~

In FIG. 6 there is shown a b],ock diagram of the detection system 32~. The detection systems 32S, 32G, 32C and 32T are substantially identical to the detection system 32A and sc only the system 32~ will be described in detail herein. The detec~ion system 32A includes an electrophoresis channel 42, a sample volume 43, a light source 44 and an optical detection system 46.
In one embodiment avidin marked with fluorescein in the ~luorescenated-avidin source flows into the gel which receives A type terminated strands from channel 26A on conduit 48 and i5 attached to the biotinylated DNA fragments. Actually, the electrophoresis channel 42 may be a gel section positioned at the end of the electrophoresis channel 26A for continuous electro-phoresing. After the fluoresceinated avidin is attached to the biotinylated DNA in the electrophoresis channel 42, the complex molecule is eluted out of the electrophoresis channel 42 into the sample volume.
'In another embodiment, the DNA may be marked by a palidrome described above and the detection system would then utilize a different wavelength of light and wou],d not require the fluorescenated-avidin source 40 but rather an ethidium bromide source 40A.
The sample volume 43 is irradiated by the light source 44. Li~ht from the light source 44 is detected ~36~

and converted to electrical signals by the optical detection system 46 for application through the eondue-tor 50A to the correlation system 34 tFIG. '). In one embodiment, the fluorescenated-avidin source 40 contains a fluorescent marker having a period of fluorescenee sufficiently long compared to background fluorescenee in the DNA and associated materials to permit significant separation of the signal from the fluoreseence. In this embodiment, the decay lifet;me of the fluoreseent marker should be at least ten times the duration of the baekground fluorescenee whieh baekground fluoreseenee is expressed in the form of noise in a detected signal.
Some known appropriate fluoreseent markers are:
(1) rare-earth organo eomplexes, eonsisting of rare earth bound to organie eompounds with ~he resulting eomplex having the desired properties, sueh as euro-pium, benzoylaeetonate and europium benzoyltrifluoro-acetonate, as discussed by S.I. Weissman in the Journal of Chemical Physics, vol. 10, page 214-217, 1942; (2) pyrenebuterate, as discussed by Knopp and Weber in the Journal of Biological Chem_ try, vol. 242, p. 1353 _ (1963) and vol. 244, p. 3609 (1969); (3) fluoreseein isothiocyanate (FITC); (4) rhodamine ~Z3~61 isothiocyanate ~RITC~; (5~ tetramethylrhodamine isothio-cyanate (TRITC); (63 phycoerythrin; and (7~ their analogs and substituted derivatives. Such materials are available commercially such as from ~esearch Organics in Cleveland, Ohio. In the preferred embodiment, fluorescein avidin DCS iS purchased Erom vector Laboratories, Inc., 1429 Rollins Road, Burlingame, CA
94010.
The light source 44 includes a pulsed light source 52 and a modulator 54. The pulsed light source 52 is selected to emit light within the absorbance spectrum of the fluorescent marker. Since different f~uorescent markers may be used, this frequency differs from fluorescent marker to fluorescent marker. Moreover, in one embodiment, the modulator 54 controls the pulsed light source 52 to select intervals between pu]ses, the intervals being provided to permit the decay of fluores-cent light from the background fluorescent material, during which time the fluorescent light from the bound markers is measured.
These time periods between pulses are suffi-ciently long to encompass the entire delay period. This is done because the delay period of the attached fluore-scent marker is relatively lonq compared to background noi~e fluorescence and so a period of time may pas.s ~6 ~L23~

before the measurement is made by the optical detection system 46. Typically, the pulse of liqht has a duration of approximately three nanoseconds and the background fluorescence decay lasts for approximately ten nano-seconds while the fluorescent marker attached to the avidin has a decay lifetime of 100 nanoseconds.
Typically, the optical detection system 46 begins reading at approximately 50 nanoseconds after the ini-tia~ion of the excitation p~lse from the laser and continues for approximate]y 150 nanoseconds until 200 nanoseconds after the initiation of the three nanosecond pulse. Although in the preferred embodiment, a pulsed laser light source 52 is ut;lized, a broad band light source combined with filters or a monochrometer may be utilized to provide the narrow band in the absorption spectrum of the marker.
Another embodiment uses an electro-optic modulator which modulates a continuous light SQUrCe at a frequency typical3y at 10 khz, with essentially 100~ depth of modulation and 50~ duty cycle. A pulse generator pro-vides a signal both to the modulator via a driver and to a lock-in amplifier as a reference signal. Another embodiment uses a continuous light source with no modulations.

123~16~L

To detect the bands in the electrophoresis gel of the electrophoresis channel 42 indicating particular DNA
fragments, the optical detection system 46 includes certain viewing optics 60, a filter 62, and an optical detection system 64. The filter 62 selects the fre-quency of light transmitted thro~lgh it by the viewing optics 60 which focuses the ligh~ onto the optical detectlon system 64. The optical detection system 64 is electrically connected ~o the modulator 54 to gate an electrical signal to the conductor 50A indicating the presence or absence of a band of DNA fragments in the electrophoresis channel 42.
The filter 62 in the preferred embodiment includes an interference filter having a pass band corresponding to the high emission spectrum of the fluorescent marker.
Such filters are known in the art and may be purchase~
from commercial sources with bands to correspond to common emission bands of fluorescent markers. In addi~
tion, there may be long-wave~ength-passing interference filters and/or colored glass filters. Another embodiment uses a monochrometer instead of a filter.
The viewing optics 60 consists of a lens system positioned in juxtaposition with filter 62 to focus light onto the optica~ detection system 64. ~t may be ~3~

any conventiona] optical system, and the optical detec-tion system 64 should include a semiconductor detector or a pho~omultiplier tube, such as the Model ~MI 9798A
made by EMI Gencon, Plainview, New York.
In the first embodiment~ the output of the photo-multiplier or semiconductor is gated in response ~o the signals from the modulator 54 to occur after a time delay after each pulse from the pulsed laser light source 52. For example, a time delay may be included before the electrical signal is applied to an amplifier and thus provide an electrical signa] to the conductor 50A or to an amplifier, the output of which is electrically connected to the conductor 50A~ In the preferred embodiment, the time delay is 50 microseconds and the gate or amplifier is maintained open by a mono-stable multivibrator for approximately 150 nanoseconds.
In the second embodiment, the square wave output of a modulator is compared with the signal from the detector using a lock-in amplifier. In a third embodiment, no modulation is performed.
In FIG. 7 there is shown a block diagram of the correlation system 34 having a standard channel input circuit 70S, a gating sys~em 72, a decoder 74, a memory 76 and a read-out system 78. ~he standard channel input circuit 70S is electrically connect2d to 3~

the OR gate 74S which is electrica]ly connected to the other channels A, G, C and T and to the gating system 72 which receives channel input signals from each of the channels A, G, C, and T s;milar to that of channel 70S.
The gate 74S is electrica1ly connected to the memory 76 which receive signals from gate 74S inaicating the presence of ~NA fragments in the particular one of the nucleic acid bases or in the standard channel. The memory 76 is electrically connected to the read-out system 78 to print out the sequence.
The standard channel input ~ircuit 70s includes a pulse shaper 82A, a binary counter 84S, a time de],ay 94S
of the clock 80 and a latch 86S with the input of the pulse shaper 82S being electrically connected to a con-auctor 50s and its output being connected to OR gate 74S
through time delay 94S and to the binary counter 84S.
The ouput of the binary counter 84S is connected to the latch 86 to provide a time increment signal ~o the latch 86, the output of which is applied to one of the inputs of memory 76 when triggered by A signa] from OR
gate 74S. The conductor 50S corresponds to conductors 50A, 50G, 50C and 50T ~FIG. 2) except that conductor 50S is the output for the standard clock channel rather than for adenine. quanine, cytosine or thym1ne.

~.230~

The latch 86 and the decoder 74 are pulsed by a signal from the ga~e 74S to write into the memory 76 for recording with a distinctive signal indicating a clock timing pulse which is later printed to indicate the time that particular DNA segments have been received and detected in the detection system 32A, 32G, 32C and 32T (FIG. 1). The binary counter ~4S receives clock pulses from clock 80 to which it is connected and thus contains a binary signal representing tlme for applica-tion to the latch 86.
The switching circuit 72 includes a dec~der 74 which is electrically connected to four inputs from channels 70A, 70G, 70C and 70T respectively, for receiving signals indicating the presence of types A, G, C, and T, fragments as they appear on input conductors 50A, 50G, 50C and 50T, (of FIG. 1 and F~G. 2). The signals on conductors 50A, 50G, 50C, and 50T are each applied to respective ones of the pulse shapers 82A, 82G, 82C, and 82~, the outputs of which are e].ectrically connected through corresponding ones of the conductors 92A, 92G, 92C, and 92T to different inpu~s of the decoder 74 and to inputs of the O~ gate 74S, so that the decoder 74 receives signals indicating the presence of a DNA fragment for application to the memory 76 upon receiving a signal on conduc~or 90S from the OR gate 3L23~ 6~

74S. The OR gate 74S applies such a signal whenreceivins a calibration signal from the channel 70S or when receiving a signal from any one of the channels 70A, 70G, 70C, and 70T, so that the memory 96 receives calibration signals or signals indicatins DNA for reading out, after a de~ay within the memory 7~, to the readout system 78.
The OR gate 74S recei.ves its calibration signal from channel 70S after a delay imparted in ~he delay llne 74S, but does not have such a corresponding delay in channel 70A, 70G, 70C, and 70T. ~owever, a similar delay is within encoder 74 to be described he~einafter so that the appearance of DNA fragments wi~l be sent to the memory 76 in a time frame corresponding to that of the calibration signals from channel 70S. The output of the decoder 74 is electrically connected to the memory 76 through a conductor 100.
In FIG. 8, there is shown a schematic circuit diagram of the decoder 74 having a delay line 94, an OR
gate 102 and a plurality of coding channels 74A, 74G, 74C and 74T to respectively indicate fra~ments termi-nating with the bases, adenine, guanine, cytoslne and thymine respectively.
The channel 74A includes AN3 gate 106, having its inputs electrically connected to conductor 92A and ~Z3~61 90A to receive on conductor 90~ a clock signal from the OR gate 7~S (FIC,. 7) and on its other input a signal indicating the presence of an adenine ter~inated frag-ment on conductor 92A.
Channel 74G includes AND gate 108, AND gate 110 and delay line 112. Conductor 92~ indicating a guanine terminated strand is electrically connected to the in~
puts of AND gate 108 and 110. The output of AND gate 108 is connected to one of the inputs of OR gate 102 and the output of AND gate 110 is electrica~.ly connected through delay line 112 to the input of OR gate 102 to provide two pulses in succession to gate 102. Thus, channel 74A applies one out pulse from the output of AND gate 106 to one of the inputs of OR gate 102, whereas channel 74G applies two pulses. In either case, the sequence of pulses indicates the presence of a particular one of the types of DNA fragments A or G.
Similarly, the channel 74C includes AND gates 3~4, 116 and 118, each having one of its two inputs electrically connected to conductor 92C and 90C and the channel 74T includes AND gates 120, 122, 124 and 126, each having one of its inputs electrically connected to conductor 92T and the other connected to 90T. The output from an AND gate 74C is electrically connected to an input of OR gate 102, the output of AND gate llÇ

6 ~

is electrically connected through a delay 128 to the input of OR gate 102, and the output of AND gate 11 is electrically connected through a delay 130 longer than the delay 128 to an input of the OR gate 106. With this arrangement, the presence of a DNA strand termina-ting ~tith cytosine results in three pulses to the OR
gate 102.
The output of AND gate 120 is electrically connected to an input of the OR gate 102, the ou~put of the AND gate 122 is electrically csnnected through a delay 132 to an input of the OR gate 102, the output of AND gate 124 is electrically connected through a delay 134 longer than the delay 132 to an input of the OR gate 102 and the output of AND gate 126 is electrically connected through a delay 136 longer than the delay 134 to an input of the OR gate 102. In this manner, the presence of a thymlne-terminated fragment results in four signals in series to the inputs of OR gate 102.
The out gate of OR gate 102 is applied through a de~ay 94 with a similar time delay as the delay 94S (FIG. 7~
to the output conductor 100 so as to provide a coded signal indicating the presence of a particular DNA group to the memory 76 ~F~G. 7) coordinated with a time signal.

~23~

In the operation of sequencing DNA, DNA strands with bases above 100 in number are first marked with biotin, separated in accordance to the size of the fragment and then marked with avidin marked with one or more fluorescent molecules. The bands are then detected by light with the read-out in the emission spectrum taking place a sufficient amount of time after excitation in the emission spectrum to screen against noise.
To mark DNA fragments with biotin, cloned strands are prepared and cleaved into frayments after which they are first marked wi~h biotin and then divided into four aliquots. A standard source of DN~ strands also marked with biotin and having different rates of migration under electrophoresis forms additional calibration batches. ~he four batches are each individual]y, randomly cleaved by a chemical treatment for a different one of adenine, guanine, cytosine and thymine bases. In the alternative, strands may be separate~ and used as templates for synthesizing randomly to a selected base tvpe. In either case, the strands may be marked with biotin, marked with an inverted complementary sequence of DNA, marked with a radioactive marker or left unmarked.

~23~3~6~

To separate the fragments, the biotin marked frag-ments including any standard ladder source are each individually electrophoresced through gel in different channels or in different columns. The gel ana the field must be uniform, although reference channels reduce uniformity requirements, and when a sing]e slab is used to migrate several different samp]es, the channe]s must be kept separate and be centered sufficiently around the field so that the potentia7 for causing them to migrate is uniform. Preferab]y, the p~ of the gel for separa-tion is 7.5-80 The DNA fragments separate ;n accordance with their length during electrophoresis. Thus, the fastest migrating fraction is the fragment which is cut or synthesized to the first base closest to the marked end of the strand and, since the channels are separate, it is known which base A, G, C or T is the first one in the sequence from the channel.
The next band in time in the gel is the next clea-vage point which is one base longer than the first one since it encompasses both the first base and the second one from the biotinylated end of the DNA strand.
Similarly, the third fragment to for~ a band during electrophoresis will encompass the first three base units and so on.

~Z3V:~6~

Because a large number of bases are used, there is a larger number of cleavage points and the density of fragments in each band is relatively low. Thus, the gel and the Eield must be selected to provide a band of sufficient width, high enough density and ade~uate sepa-ration for detection. The gel slab is sufficienty long such that the first bands to be moved completely through the gel are fully resolved while the last bands are unresolved in a continuous process. More specifically, at least 10 percent of the bands are resolved and electrophoresed through ~he gel while the least mobile bands are yet unresolved near the entrance end oE ~he gel.
To provide light amplification for measurement of the low density bands in one embodiment, the bands are electrophoresced into a region where they are mixed with avidin marked with one or more fluorescent molecules. Because avidin is a large molecule and strongly attracted to the biotin, the DNA fragments in each band, as they are moved into a fluorescent-marked avidin region, are marked with avidin~ ~fter being marked with avidin such as indicated at 32S, 32A, 32G, 32C and 32T (FIG. 1), they are each moved through a detection system such as the one illustrated in FIG~ 2.

~23v~e~l Because the avidin molecules are large, a number of fluorescent markers are at~ached to the same avidin molecule thus providing adequa~e detection. The fluore-scent-marked fragments are then moved into the samp]e volume within the detection system where they maintain their relative order. The movement must be sufficiently rap;d in the gel so that minimum resolution is lost.
The bands are eluted into the sample volume where individual light sources apply pulsed or chopped light within the optimum absorption spectrum of the f]uore-scent marker or ethidium bromide marker in the second embodiment of approximately three nanoseconds duration.
The light is sensed by a detector approximately fifty nanoseconds after the beginning of the three nanosecond pulse of light and the resulting electrical signal is amplified. This light is detected and corre~ated to provide the sequence of DNA in accordance with the channel as indicated by a detector at the end of each of the detection systems.
As can be understood from the above description, the DNA sequencing system of this invention enables continuous sequencing and thus may handle in a con-tinuous, automatic manner, a large number of bases.
This is accomplished by the combination of continuous electrophorescing with the amplification provided by 3~

the avidin attachment at the end of the first separa~
tion.
Although a preferred embodiment of the invention has been described with some particularity, many modi-fications and variations are possible in the preferred embodiment within the light of the above description.
Accordingly, within the scope of the appended claims, the invention may be practiced other ~han as specifi-cally described.

Claims (18)

The embodiments of the invention for which an exclusive right or privilege is claimed are:
1. A method for sequencing DNA comprising the steps of:
preparing cloned DNA strands;
preparing from the cloned DNA strands fragmented DNA strands with random lengths terminating at different ones of the adenine base, guanine base, cytosine base and thymine base and marking the pieces;
applying samples of the fragmented DNA strands after terminating at their respective bases to at least one channel of separating aparatus;
separating the strands within at least one channel so that the first bands to be moved completely through the channels are fully resolved while the last bands are unresolved in a continuous process such that at least ten percent of the bands are resolved and moved through the channels while the least mobile bands are yet unresolved near the entrance end of the channel; and identifying and recording the time sequence of the bands in the channel and whether the termination is at an adenine base, guanine base, thymine base or cytosine base in the band.
2. A method according to claim 1 in which the step of separating includes the step of separating the strands by gel electrophoresis.
3. A method according to claim 1 in which the step of separating includes the step of separating the strands by HPLC.
4. A method according to any of claims 1 through 3 in which the step of preparing a first batch includes the step of cleaving the strands at an adenine on pieces with random lengths.
5. A method according to any of claims 1 through 3 further including the step of preparing four batchs of fragments each batch being terminated at a different one of A, G, C and T bases and the step of separating includes the step of separating each batch in a corres-ponding channel.
6. A method according to any of claims 1 through 3 including the steps of applying at least one calibration time base source of DNA to at least one channel.
7. A method according to any of claims 1 through 3 further including the step of identifying strands terminating at different bases.
8. A method according to any of claims 1 through 3 in which the step of identifying includes the steps of:
marking the DNA strands on one end with biotin before separating;
attaching fluorescent markers to the avidin; and moving said bands sequentially from the gel while maintaining each fragment in each channel separate into a means for marking with fluorescent-marked aviden by combining the fluorescent avidin with the biotin end markers.
9. A method according to any of claims 1 through 3 in which the step of identifying further includes the steps of:
moving the bands in sequence through a medium;
scanning said bands with laser light having a nar-row band width substantially conforming to the optimum adsorption spectrum of the fluorescent markers;
pulsing the laser light with pulses of shorter duration than three nanoseconds;

detecting the fluorescent emission from the marker across a narrow selective band width conforming substan-tially to the optimum emission spectrum of the markers through a second period of time;
said second period of time beginning at least fifty nanoseconds from the start of its corresponding pulse of laser light and terminating at a time no greater than one hundred fifty nanoseconds from the start of the pulse of the laser light; and identifying and recording the time sequence of each of the channels so as to indicate the sequence of DNA
fragments.
10. Apparatus for performing DNA sequencing comprising:
separating apparatus;
said separating apparatus having at least one channel and at least one channel-introducing section adapted to receive DNA fragments terminated at different ones of the four nucleic acid molecules, A, G, C and T;
means for removing separated bands of the DNA
fragments from the end of said separating apparatus prior to the resolution of the last to be resolved bands; and means for sensing four separate groups of DNA
fragments in accordance with the terminating base.
11. Apparatus in accordance with claim 10 in which said separating apparatus is a gel electrophoresis apparatus.
12. Apparatus in accordance with claim 10 in which said separating apparatus is capillary chromatographic equipment.
13. Apparatus according to any of claims 10 through 12 further including:
means for marking said DNA fragments prior to their entrance into the electrophoresis gel with biotin;
means for attaching a fluorescent marker to avidin;
means for marking said DNA fragments after they have been electrophoresed through said electrophoresis apparatus with fluorescenated avidin;
means for selectively pulsing said markers with light;
means for detecting the fluorescence of said marker across a time period in which background fluorescence is reduced; and said means for detecting including means for converting said fluorescence into electrical signals indicating the time sequence of bands of DNA marked with fluorescence corresponding to each of the DNA fragments cleaved at different ones of the nucleic acid groups.
14. Apparatus for performing DNA sequencing comprising:
first gel electrophoresis apparatus;
said first gel electrophoresis apparatus having at least four separate channel-introducing sections each adapted to receive DNA fragments cleaved at different ones of the four nucleic acid molecules, A, G, C and T;
and means for electrophoresing separated bands of the DNA fragments from the end of said electrophoresis apparatus prior to the resolution of the last to be resolved bands.
15. Apparatus according to claim 14 further comprising:
means for marking said DNA fragments prior to their entrance into the electrophoresis gel with biotin;
said means for electrophoresing said bands from said gel including means for maintaining four separate groups of DNA fragments in accordance with the nucleic acid molecule at which they were cleaved;
means for marking said DNA fragments after they have been electrophoresed through said electrophoresis apparatus with avidin; and means for attaching a fluorescent marker to said avidin.
16. Apparatus according to claim 15 further including:
means for selectively pulsing said markers with light;
means for detecting the fluorescence of said marker across a time period in which background fluorescence is reduced; and said means for detecting including means for converting said fluorescence into electrical signals indicating the time sequence of bands of DNA marked with fluorescence corresponding to each of the DNA fragments cleaved at different ones of the nucleic acid groups.
17. Apparatus for performing DNA sequencing comprising:
first gel electrophoresis apparatus;

said first gel electrophoresis apparatus including at least four separate tubes each adapted to receive DNA
fragments terminated at different ones of the four bases, A, G, C and T; and means for electrophoresing separated bands of the DNA fragments from the end of said electrophoresis apparatus prior to the resolution of the last to be resolved bands.
18. Apparatus according to claim 17 further comprising:
means for marking said DNA fragments prior to their entrance into the electrophoresis gel with biotin;
said means for electrophoresing said bands from said gel including means for maintaining four separate groups of DNA fragments in accordance with the nucleic acid molecule at which they were cleaved;
means for marking said DNA fragments after they have been electrophoresed through said electrophoresis apparatus with avidin; and means for attaching a fluorescent marker to said avidin.
CA000477173A 1984-03-29 1985-03-21 Dna sequencing Expired CA1230161A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/594,676 US4729947A (en) 1984-03-29 1984-03-29 DNA sequencing
US594,676 1984-03-29

Publications (1)

Publication Number Publication Date
CA1230161A true CA1230161A (en) 1987-12-08

Family

ID=24379901

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000477173A Expired CA1230161A (en) 1984-03-29 1985-03-21 Dna sequencing

Country Status (6)

Country Link
US (3) US4729947A (en)
EP (1) EP0157280B1 (en)
JP (1) JPH0743347B2 (en)
AU (1) AU588229B2 (en)
CA (1) CA1230161A (en)
DE (1) DE3583516D1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356773A (en) * 1989-05-16 1994-10-18 Kinetic Investments Limited Generation of unidirectional deletion mutants

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5207880A (en) * 1984-03-29 1993-05-04 The Board Of Regents Of The University Of Nebraska DNA sequencing
US4729947A (en) * 1984-03-29 1988-03-08 The Board Of Regents Of The University Of Nebraska DNA sequencing
US5863403A (en) * 1984-03-29 1999-01-26 The Board Of Regents Of The University Of Nebraska Digital DNA typing
US4870004A (en) * 1984-06-08 1989-09-26 Autoseq, Inc. Apparatus and method of analyzing nucleic acid molecules
US4617102A (en) * 1985-03-21 1986-10-14 Lifecodes Corp. Process and apparatus for purifying and concentrating DNA from crude mixtures containing DNA
EP0199327B1 (en) * 1985-04-19 1992-03-04 Fuji Photo Film Co., Ltd. Signal processing method for determining base sequence of nucleic acids
US4811218A (en) * 1986-06-02 1989-03-07 Applied Biosystems, Inc. Real time scanning electrophoresis apparatus for DNA sequencing
DE3618605A1 (en) * 1986-06-03 1987-12-10 Europ Lab Molekularbiolog DEVICE FOR DETECTING SUBSTANCES INCENTIVELY TO PHOTON EMISSION
JPH07113606B2 (en) * 1986-10-27 1995-12-06 株式会社島津製作所 Nucleotide sequencer
GB8626575D0 (en) * 1986-11-06 1986-12-10 Amersham Int Plc Biochemical sequencing
US5145776A (en) * 1987-01-14 1992-09-08 President & Fellows Of Harvard College Method of using T7 DNA polymerase to mutagenize and fill-in DNA
US4946786A (en) * 1987-01-14 1990-08-07 President And Fellows Of Harvard College T7 DNA polymerase
US5266466A (en) * 1987-01-14 1993-11-30 President And Fellows Of Harvard College Method of using T7 DNA polymerase to label the 3' end of a DNA molecule
US4942130A (en) * 1987-01-14 1990-07-17 President & Fellows Of Harvard College T7 DNA polymerase
US4994372A (en) * 1987-01-14 1991-02-19 President And Fellows Of Harvard College DNA sequencing
JPH0785058B2 (en) * 1987-01-30 1995-09-13 株式会社島津製作所 Nucleotide sequence determination method
JPH0799353B2 (en) * 1987-03-31 1995-10-25 株式会社島津製作所 Nucleotide sequencer
DE3752148T2 (en) * 1987-06-09 1998-09-17 Perkin Elmer Corp Real time scanner in an electrophoresis apparatus for DNA sequence determination
US4833332A (en) * 1987-06-12 1989-05-23 E. I. Du Pont De Nemours And Company Scanning fluorescent detection system
DE3821454A1 (en) * 1987-06-24 1989-02-09 Hitachi Ltd METHOD FOR PROCESSING USED ELECTROPHORESE GELS FOR REUSE
US4942124A (en) * 1987-08-11 1990-07-17 President And Fellows Of Harvard College Multiplex sequencing
EP0317239A3 (en) * 1987-11-13 1990-01-17 Native Plants Incorporated Method and device for improved restriction fragment length polymorphism analysis
DE3816934A1 (en) * 1988-05-18 1989-11-23 Ramalho Ortigao Jose Flavio NEW SEQUENCING METHOD FOR SINGLE OR DOUBLE-STROKEN NUCLEINE ACIDS AT FIXED PHASE
US5817797A (en) * 1988-06-01 1998-10-06 The United States Of America As Represented By The Department Of Health And Human Services Sequencing DNA; a modification of the polymerase chain reaction
US5003059A (en) * 1988-06-20 1991-03-26 Genomyx, Inc. Determining DNA sequences by mass spectrometry
US4962020A (en) * 1988-07-12 1990-10-09 President And Fellows Of Harvard College DNA sequencing
US4936974A (en) * 1988-11-03 1990-06-26 The University Of North Carolina At Chapel Hill Capillary separation system with electric field assisted post separation mixing
USRE35102E (en) * 1989-06-01 1995-11-28 The Board Of Trustees Of The Leland Stanford Junior University Capillary electrophoretic device employing structure permitting electrical contact through ionic movement
US5274240A (en) * 1990-01-12 1993-12-28 The Regents Of The University Of California Capillary array confocal fluorescence scanner and method
US5270214A (en) * 1990-05-30 1993-12-14 The United States Of America As Represented By The United States Department Of Energy Method for sequencing DNA base pairs
US5935522A (en) * 1990-06-04 1999-08-10 University Of Utah Research Foundation On-line DNA analysis system with rapid thermal cycling
US5119316A (en) * 1990-06-29 1992-06-02 E. I. Du Pont De Nemours And Company Method for determining dna sequences
US5269900A (en) * 1990-09-13 1993-12-14 University Of North Carolina At Chapel Hill Method and device for high speed separation of complex molecules
WO1992013629A1 (en) * 1991-01-31 1992-08-20 Wayne State University A method for analyzing an organic sample
US5167784A (en) * 1991-09-04 1992-12-01 Xerox Corporation Sequencing large nucleic acid fragments
US5273638A (en) * 1991-09-30 1993-12-28 Beckman Instruments, Inc. Nucleotide sequence determination employing matched dideoxynucleotide terminator concentrations
US5213669A (en) * 1992-01-31 1993-05-25 Beckman Instruments, Inc. Capillary column containing a dynamically cross-linked composition and method of use
US6436635B1 (en) * 1992-11-06 2002-08-20 Boston University Solid phase sequencing of double-stranded nucleic acids
US5795714A (en) * 1992-11-06 1998-08-18 Trustees Of Boston University Method for replicating an array of nucleic acid probes
US6194144B1 (en) 1993-01-07 2001-02-27 Sequenom, Inc. DNA sequencing by mass spectrometry
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
US5324401A (en) * 1993-02-05 1994-06-28 Iowa State University Research Foundation, Inc. Multiplexed fluorescence detector system for capillary electrophoresis
JPH06265447A (en) * 1993-03-16 1994-09-22 Hitachi Ltd Trace quantity reactor and trace element measuring instrument therewith
US5503994A (en) * 1993-10-08 1996-04-02 The Board Of Trustees Of The Leland Stanford Junior University System for sample detection with compensation for difference in sensitivity to detection of components moving at different velocities
US5538613A (en) * 1993-10-26 1996-07-23 Genesys Technologies, Inc. Electrophoresis analyzer
US5710628A (en) * 1994-12-12 1998-01-20 Visible Genetics Inc. Automated electrophoresis and fluorescence detection apparatus and method
US6428955B1 (en) 1995-03-17 2002-08-06 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US7803529B1 (en) * 1995-04-11 2010-09-28 Sequenom, Inc. Solid phase sequencing of biopolymers
US20060063193A1 (en) * 1995-04-11 2006-03-23 Dong-Jing Fu Solid phase sequencing of double-stranded nucleic acids
US5582705A (en) * 1995-05-19 1996-12-10 Iowa State University Research Foundation, Inc. Multiplexed capillary electrophoresis system
US5830655A (en) 1995-05-22 1998-11-03 Sri International Oligonucleotide sizing using cleavable primers
US5888736A (en) * 1995-12-22 1999-03-30 Visible Genetics, Inc. Method, compositions and kit for detection and identification of microorganisms
US5789168A (en) * 1996-05-01 1998-08-04 Visible Genetics Inc. Method for amplification and sequencing of nucleic acid polymers
US5830657A (en) * 1996-05-01 1998-11-03 Visible Genetics Inc. Method for single-tube sequencing of nucleic acid polymers
US6083699A (en) * 1996-05-01 2000-07-04 Visible Genetics Inc. Method for bi-directional sequencing of nucleic acid polymers
US6214555B1 (en) 1996-05-01 2001-04-10 Visible Genetics Inc. Method compositions and kit for detection
US6413718B1 (en) 1996-05-01 2002-07-02 Visible Genetics Inc. Method for sequencing of nucleic acid polymers
US6133436A (en) 1996-11-06 2000-10-17 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
DK0937096T3 (en) 1996-11-06 2004-06-14 Sequenom Inc Method of mass spectrometry analysis
DE19782095T1 (en) * 1996-11-06 2000-03-23 Sequenom Inc DNA diagnosis based on mass spectrometry
US6140053A (en) * 1996-11-06 2000-10-31 Sequenom, Inc. DNA sequencing by mass spectrometry via exonuclease degradation
CA2281205A1 (en) 1997-02-12 1998-08-13 Eugene Y. Chan Methods and products for analyzing polymers
US5903348A (en) * 1997-03-12 1999-05-11 Nz Applied Technologies, Inc. System and method for molecular sample measurements
US6084667A (en) * 1997-03-12 2000-07-04 Nz Applied Technologies System and method for molecular sample measurement
US6445448B1 (en) 1997-03-12 2002-09-03 Corning Applied Technologies, Corp. System and method for molecular sample measurement
US6136172A (en) * 1997-06-30 2000-10-24 Visible Genetics Inc. Gel-forming insert for electrophoresis gels
AU9476598A (en) * 1997-09-11 1999-03-29 Seq, Ltd. Method to make fluorescent nucleotide photoproducts for dna sequencing and analysis
US6268131B1 (en) 1997-12-15 2001-07-31 Sequenom, Inc. Mass spectrometric methods for sequencing nucleic acids
US6232103B1 (en) 1998-03-23 2001-05-15 Invitrogen Corporation Methods useful for nucleic acid sequencing using modified nucleotides comprising phenylboronic acid
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US6723564B2 (en) 1998-05-07 2004-04-20 Sequenom, Inc. IR MALDI mass spectrometry of nucleic acids using liquid matrices
US6743605B1 (en) 1998-06-24 2004-06-01 Enzo Life Sciences, Inc. Linear amplification of specific nucleic acid sequences
US8445664B2 (en) * 1998-06-24 2013-05-21 Enzo Diagnostics, Inc. Kits for amplifying and detecting nucleic acid sequences
US6497804B1 (en) * 1998-12-03 2002-12-24 Research Foundation Of The State University Of New York Method and apparatus for DNA sequencing
WO2001073121A1 (en) 2000-03-30 2001-10-04 Toyota Jidosha Kabushiki Kaisha Method of determining base sequence of single nucleic acid molecule
US6912469B1 (en) 2000-05-05 2005-06-28 Kenneth J. Cool Electronic hybridization assay and sequence analysis
US6495812B1 (en) 2000-08-02 2002-12-17 Li-Cor, Inc. Apparatus and method for analyzing an object of interest having a pivotably movable source and detector
US6548251B1 (en) 2000-09-05 2003-04-15 Fidelity Systems, Inc. Inhibition of molecular and biological processes using modified oligonucleotides
WO2002044425A2 (en) 2000-12-01 2002-06-06 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
US7668697B2 (en) 2006-02-06 2010-02-23 Andrei Volkov Method for analyzing dynamic detectable events at the single molecule level
US6838289B2 (en) * 2001-11-14 2005-01-04 Beckman Coulter, Inc. Analyte detection system
US7222059B2 (en) * 2001-11-15 2007-05-22 Siemens Medical Solutions Diagnostics Electrophoretic trace simulator
WO2004003510A2 (en) * 2002-07-01 2004-01-08 Guava Technologies, Inc. Fluorescent dyes, energy transfer couples and methods
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
WO2005080605A2 (en) 2004-02-19 2005-09-01 Helicos Biosciences Corporation Methods and kits for analyzing polynucleotide sequences
WO2006089268A2 (en) * 2005-02-18 2006-08-24 The University Of North Carolina At Chapel Hill Gene and cognate protein profiles and methods to determine connective tissue markers in normal and pathologic conditions
US7939613B2 (en) * 2005-04-22 2011-05-10 The Hong Kong University Of Science And Technology Fluorescent water-soluble conjugated polyene compounds that exhibit aggregation induced emission and methods of making and using same
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
AU2010257118B2 (en) 2009-06-04 2014-08-28 Lockheed Martin Corporation Multiple-sample microfluidic chip for DNA analysis
CA2814720C (en) 2010-10-15 2016-12-13 Lockheed Martin Corporation Micro fluidic optic design

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423207A (en) * 1964-09-01 1969-01-21 Eastman Kodak Co Solubilized styryl dyes
US3873432A (en) * 1972-10-30 1975-03-25 Louis Israel Continuous preparative electrophoresis method
US4166105A (en) * 1973-07-30 1979-08-28 Block Engineering, Inc. Dye tagged reagent
US3969218A (en) * 1975-02-11 1976-07-13 The United States Of America As Represented By The United States Energy Research And Development Administration Elution electrophoresis
US4138551A (en) * 1975-03-18 1979-02-06 Ciba-Geigy Ag Spectral sensitization of photographic material and new spectral sensitizers
DE2523209A1 (en) * 1975-05-26 1976-12-16 Noeller Hans Guenter Dr Med ELECTRO-OPTIC, SUBSTANCE-CARE DETECTION OF NON-CELL-BONDED IMMUNE SUBSTANCES
GB1529202A (en) * 1976-02-20 1978-10-18 Ciba Geigy Ag Spectral sensitising dyes
NL182822C (en) * 1976-05-18 1988-05-16 Roskam Willem Gerrit PREPARATIVE ELECTROFORESE DEVICE.
US4198567A (en) * 1977-10-25 1980-04-15 Peter Eneroth Method and apparatus for discrimination between scattered excitation radiation and low level fast decaying fluorescent radiation
US4284491A (en) * 1978-11-13 1981-08-18 C. Desaga Gmbh Nachf. Erich Fecht Apparatus for electrophoresis
US4503035B1 (en) * 1978-11-24 1996-03-19 Hoffmann La Roche Protein purification process and product
US4239612A (en) * 1979-02-28 1980-12-16 Pen Kem, Inc. Automatic electrophoresis apparatus
US4351709A (en) * 1979-02-28 1982-09-28 Goetz Philip J Method of obtaining the mean electrophoretic mobility of particles
JPS55116259A (en) * 1979-03-01 1980-09-06 Fuji Photo Film Co Ltd Microimmunoassay method
US4256834A (en) * 1979-04-09 1981-03-17 Syva Company Fluorescent scavenger particle immunoassay
DE3022527C2 (en) * 1980-06-16 1985-01-31 Fritz Prof. Dr. 7750 Konstanz Pohl Method for electrophoretic separation and device therefor
JPS5745460A (en) * 1980-09-02 1982-03-15 Fuji Photo Film Co Ltd Inspection sheet for measuring trace component and inspecting method using said sheet
DE3170135D1 (en) * 1980-09-02 1985-05-30 Fuji Photo Film Co Ltd Method for immunochemical measurement of trace components
JPS5747493A (en) * 1980-09-02 1982-03-18 Fuji Photo Film Co Ltd Method of determining a trace amount of enzyme
US4534647A (en) * 1981-02-23 1985-08-13 Institut Molekulyarnoi Biologii Biokhimii Akademii Nauk Kazakhskoi SSR Apparatus for photometrically scanning gels
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
US4375401A (en) * 1981-05-20 1983-03-01 Nicholas Catsimpoolas Electrophoresis system
FR2519005B1 (en) * 1981-12-29 1985-10-25 Pasteur Institut DNA FRAGMENTS MARKED WITH AT LEAST ONE OF THEIR ENDS ENDANGERED BY MODIFIED RIBONUCLEOTIDES RECOGNIZABLE BY AFFINOUS MOLECULES AND METHOD FOR CARRYING OUT ANALYSIS OF SUCH DNA FRAGMENTS
US5241060A (en) * 1982-06-23 1993-08-31 Enzo Diagnostics, Inc. Base moiety-labeled detectable nucleatide
US4948882A (en) * 1983-02-22 1990-08-14 Syngene, Inc. Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
JPS59228156A (en) * 1983-06-10 1984-12-21 Hitachi Ltd Apparatus for automatically determining arrangement of nucleic acid base
US5171534A (en) * 1984-01-16 1992-12-15 California Institute Of Technology Automated DNA sequencing technique
US5346603A (en) * 1984-03-29 1994-09-13 The Board Of Regents Of The University Of Nebraska DNA sequencing
US5230781A (en) * 1984-03-29 1993-07-27 Li-Cor, Inc. Sequencing near infrared and infrared fluorescence labeled DNA for detecting using laser diodes
US5571388A (en) * 1984-03-29 1996-11-05 Li-Cor, Inc. Sequencing near infrared and infrared fluorescense labeled DNA for detecting using laser diodes and suitable labels thereof
US4729947A (en) * 1984-03-29 1988-03-08 The Board Of Regents Of The University Of Nebraska DNA sequencing
US5366603A (en) * 1984-03-29 1994-11-22 Li-Cor, Inc. Sequencing near infrared and infrared fluorescence labeled DNA for detecting useing laser diodes
US4545888A (en) * 1984-04-06 1985-10-08 Walsh J William Apparatus for electrophoretic recovery of nucleic acids and other substances
US4870004A (en) * 1984-06-08 1989-09-26 Autoseq, Inc. Apparatus and method of analyzing nucleic acid molecules
JPS62123454A (en) * 1985-08-08 1987-06-04 Fuji Photo Film Co Ltd Silver halide photographic sensitive material
DE3529478A1 (en) * 1985-08-16 1987-02-19 Boehringer Mannheim Gmbh 7-DESAZA-2'DESOXYGUANOSINE NUCLEOTIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR NUCLEIC ACID SEQUENCING
US4707235A (en) * 1985-10-16 1987-11-17 Pharmacia, Inc. Electrophoresis method and apparatus having continuous detection means
US4910300A (en) * 1985-12-11 1990-03-20 Chiron Corporation Method for making nucleic acid probes
US4855225A (en) * 1986-02-07 1989-08-08 Applied Biosystems, Inc. Method of detecting electrophoretically separated oligonucleotides
US5039818A (en) * 1986-02-27 1991-08-13 Syntex (U.S.A.) Inc. Squaraine dye
US4830786A (en) * 1986-02-27 1989-05-16 Syntex (U.S.A.) Inc. Squaraine dyes
US5268486A (en) * 1986-04-18 1993-12-07 Carnegie-Mellon Unversity Method for labeling and detecting materials employing arylsulfonate cyanine dyes
US5091519A (en) * 1986-05-01 1992-02-25 Amoco Corporation Nucleotide compositions with linking groups
US4811218A (en) * 1986-06-02 1989-03-07 Applied Biosystems, Inc. Real time scanning electrophoresis apparatus for DNA sequencing
CA1340806C (en) * 1986-07-02 1999-11-02 James Merrill Prober Method, system and reagents for dna sequencing
US5242796A (en) * 1986-07-02 1993-09-07 E. I. Du Pont De Nemours And Company Method, system and reagents for DNA sequencing
US5151507A (en) * 1986-07-02 1992-09-29 E. I. Du Pont De Nemours And Company Alkynylamino-nucleotides
US5047519A (en) * 1986-07-02 1991-09-10 E. I. Du Pont De Nemours And Company Alkynylamino-nucleotides
US4810348A (en) * 1987-03-16 1989-03-07 Helena Laboratories Corporation Automatic electrophoresis apparatus and method
US4833332A (en) * 1987-06-12 1989-05-23 E. I. Du Pont De Nemours And Company Scanning fluorescent detection system
US4927265A (en) * 1988-04-29 1990-05-22 501 Microphoretic Systems, Inc. Detector for fluorescence and absorption spectroscopy
US4981977A (en) * 1989-06-09 1991-01-01 Carnegie-Mellon University Intermediate for and fluorescent cyanine dyes containing carboxylic acid groups
US5366860A (en) * 1989-09-29 1994-11-22 Applied Biosystems, Inc. Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
US5188934A (en) * 1989-11-14 1993-02-23 Applied Biosystems, Inc. 4,7-dichlorofluorescein dyes as molecular probes
US5326692B1 (en) * 1992-05-13 1996-04-30 Molecular Probes Inc Fluorescent microparticles with controllable enhanced stokes shift
US5187085A (en) * 1990-09-28 1993-02-16 Applied Biosystems, Inc. Nucleic acid sequence analysis with nucleoside-5'-o-(1-thiotriphosphates)
US5276143A (en) * 1990-12-21 1994-01-04 E. I. Du Pont De Nemours And Company Dideoxyfructonucleosides and deoxyfructonucleotides
US5438131A (en) * 1992-09-16 1995-08-01 Bergstrom; Donald E. 3-nitropyrrole nucleoside
DE4326466A1 (en) * 1993-08-06 1995-02-09 Boehringer Mannheim Gmbh Infrared dye-labeled nucleotides and their use in nucleic acid detection
FR2709761B1 (en) * 1993-09-10 1995-11-24 Pasteur Institut Method for detecting molecules containing nucleotide mismatches and for locating these mismatches, and application to the detection of base substitutions or deletions.
US5538613A (en) * 1993-10-26 1996-07-23 Genesys Technologies, Inc. Electrophoresis analyzer
AU3008595A (en) * 1994-06-30 1996-01-25 Biometric Imaging, Inc. N-heteroaromatic ion and iminium ion substituted cyanine dyes for use as fluorescence labels

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356773A (en) * 1989-05-16 1994-10-18 Kinetic Investments Limited Generation of unidirectional deletion mutants

Also Published As

Publication number Publication date
AU588229B2 (en) 1989-09-14
AU4002185A (en) 1985-10-03
EP0157280A3 (en) 1988-08-03
EP0157280B1 (en) 1991-07-24
US6143151A (en) 2000-11-07
JPH0743347B2 (en) 1995-05-15
EP0157280A2 (en) 1985-10-09
US4729947A (en) 1988-03-08
JPS612077A (en) 1986-01-08
DE3583516D1 (en) 1991-08-29
US6143153A (en) 2000-11-07

Similar Documents

Publication Publication Date Title
CA1230161A (en) Dna sequencing
US5207880A (en) DNA sequencing
US6200748B1 (en) Tagged extendable primers and extension products
GB2155176A (en) Sequencing DNA
EP0294524B1 (en) Real time scanning electrophoresis apparatus for DNA sequencing
US5346603A (en) DNA sequencing
EP0592060B1 (en) Digital DNA typing
JP2628571B2 (en) Oligonucleotide analyzer
US6436641B1 (en) Method and apparatus for DNA sequencing
JPH01112147A (en) Method for determining base sequence of nucleic acid
JPS61173158A (en) Method of determining arrangement of deoxyribonucleic acid
US5549805A (en) Digital DNA typing
Middendorf et al. DNA sequencing
US6576104B1 (en) Apparatus and method for reading gel electrophoresis pattern
US5961801A (en) DNA separation electrophoresis gels and methods for their use
JP2826366B2 (en) Fluorescence detection type electrophoresis device
Kheterpal et al. DNA sequencing using four-color capillary array electrophoresis and energy-transfer primers
JPH06174694A (en) Gene segragating and detecting apparatus
JPH1090223A (en) Electrophoretic device
JPH08211017A (en) Dna base sequence determining apparatus
JPH09222418A (en) Dna sequencing device
JPH01245160A (en) Method of determining base sequence of nucleic acid
JPS63222264A (en) Determination of base sequence of nucleic acid by chemiluminescence detection
JPH1048182A (en) Decision apparatus for base sequence

Legal Events

Date Code Title Description
MKEX Expiry